ABSTRAm. Chronic reserpine treatment of adult rats results in the accumulation of pancreatic enzymes and reduction of their discharge. These changes are reminiscent of those in cystic fibrosis. Since the majority of cystic fibrosis patients have their pancreatic dysfunction manifested in childhood, we studied chronic reserpine treatment in rat pups. Four-day-old rat pups were given reserpine (50 & k g intraperitoneally) or vehicle daily until sacrifice. The reserpine group showed significant decreases in%ody weights at 14 and 21 days of age. Pancreatic weights were also decreased but were of normal weight or increased when normalized against body weights. At 14 and 21 days of age, pancreatic concentrations of amylase, lipase, and trypsinogen showed no difference between reserpine and control pups. At both ages, pancreatic contents of all three enzymes were generally less in the treated pups, but were found to be similar ahen corrected for body weights. Hydrocortisone treatment of 14-day-old pups caused precocious accumulation of pancreatic enzymes in both reserpine and control groups.
Intestinal contents of lipase, trypsin, and amylase were decreased in the reserpine pups at 14 days of age and reached a more significant level at 21 days of age; these data suggest a decrease in the secretion of pancreatic enzymes. Dispersed acini from 14-day-old pups showed a reduced capacity to release amylase as stimulated by carbachol or the octapeptide of cholecystokinin. The results suggested that chronic reserpine treatment of pups in the suckling period did not cause significant disturbance of the developmental accumulation of pancreatic enzymes. A definite inhibition of exocrine secretion was found with reserpine treatment. In terms of suppression of enzyme secretion, the results with reserpinized pups resemble the conditions found in cystic fibrosis. (Pediatr Res 18:1300 Res 18: -1304 Res 18: , 1984 In adult rats, chronic administration of reserpine produces characteristic morphological and biochemical changes in the exocrine pancreas. Morphological changes include an accumulation of secretory granules and a slight reduction in rough endoplasmic reticulum in acinar cells (14, 17) . Granule discharge is reduced upon stimulation with cholecystokinin and is accompanied by the appearance of numerous autophagic bodies ( 1 7). Zymogen granules isolated from the pancreases of reserpine-treated rats have higher specific activities of proteases as compared to control animals. This has been interpreted as an increase of biosynthesis and of intracellular tranport of proteins (10) . The in vivo secretory response to stimulation with caerulein is characteized by a decrease in volume and amylase output (1). In many ways, the pancreatic dysfunction in chronically treated rats resembles that found in the pancreases of cystic fibrosis patients and therefore has been proposed as an experimental model for the disease (6) . Since a majority of CF patients have their pancreatic symptoms manifested early in life (18, 19) , it may be more appropriate to examine the animal model at a much younger developmental stage. We undertook the following study to investigate the effect of chronic administration of reserpine on the pancreases of suckling rats by assessing (i) their ability to accumulate pancreatic enzymes, (ii) their responses to precocious induction with hydrocortisone, and (iii) their secretory functions in vivo and in vitro.
MATERIALS AND METHODS
Pregnant mothers of Sprague-Dawley rats were obtained commercially on the 15th day of gestation and housed individually with a 12-h lightidark cycle. The day of birth was taken as day 0. At day 1, all pups were removed, pooled, and redistributed such that each mother had 12 pups (normal litter size, [14] [15] [16] Collection of intestinal contents. The whole small intestine from the pylorus to the ileocecal region was removed. Intestinal contents were collected by flushing with 2 ml of chilled normal saline through the lumen.
Preparation of samples. Pancreatic tissue was minced with a sharp scissors. Tissue preparations and intestinal contents were then separately homogenized with a Potter-Elvehjem homogenizer using a motor-driven Teflon pestle with the vessel immersed in crushed ice. Pancreatic homogenates and samples of intestinal contents were sonicated before use for subsequent biochemical determinations.
Biochemical determinations. Protein was determined by the technique of Lowry et al. (9) using bovine serum albumin fraction V as the standard. DNA was measured by the colorimetric reaction with diphenylamine reagent according to Burton (2) by using highly polymerized calf thymus DNA as the standard. A modified procedure was adapted to minimize the interference by sialic acids according to Croft and Lubran (3).
Trypsinogen was first activated with enterokinase, at a constant ratio of enterokinase/homogenate proteins for 45 min at 25" C; these conditions have yielded optimal and reproducible activation of this zymogen in our laboratory. The enterokinase used was partially purified from mucosa of the proximal small intestine of rats following the procedure of Baratti et al. Preparation of dispersed acini and in vitro assay of secretagogue-stimulated amylase release. Dispersed acini from the rat pancreas were prepared according to a previously published procedure (7) . The standard incubation medium contained 25 mM N-2-hydroxyethylpiperazine-N'-2-ethanesulfonic acid (pH 7.4), 98 mM NaCl, 6 mM KCl, 2.5 mM NaH2P04, 5 mM Na pyruvate, 5 mM fumarate, 5 mM Na glutamate, 11.5 mM glucose, 0.5 mM CaC12, 2 mM glutamine, 5 mM theophylline, 1 % (wt/vol) albumin, 0.1 % (wt/vol) soybean trypsin inhibitor, 1 % (vol/vol) essential amino acid mixture, and 1 % (vol/vol) essential vitamin mixture. The release of amylase into the extracellular medium in the presence and absence of secretagogue was measured as reported previously (7) . In all incubations, the gas phase was 100% O2 and all the solutions were equilibrated with 100% 02. TO ensure uniformity in the treatment of the acini, pancreases from both control and treated rats were treated simultaneously with the same batch of purified collagenase (twice with 46 units in 3 ml of buffer for 7 min each time).
Amylase release was measured as the percentage of amylase activity in the acini at the beginning of the incubation that was released into the extracellular medium during a 15-min incubation with and without secretagogues. All incubations with the secretagogue were done in triplicate. For each experiment, 2-3 pups were sacrificed.
Statistics. All results are presented as mean + SD. Differences between any two groups were evaluated by unpaired Student's t test with p < 0.05 considered as significant.
RESULTS
The developmental changes in body weight and other somatic parameters of the pancreas are summarized in Table 1 . Chronic reserpine treatment led to significant decreases in body weight in both 14-and 21-day-old pups. In reserpine-treated pups, the total pancreatic mass showed a slight decrease at 14 days which became significant in one experimental group at 2 1 days. However, when the data were corrected for body weight (i.e. expressed weight of pancreas/100 g of body weight), relative pancreatic weight on average was increased. In comparison, the liver weights per animal exhibited a significant decrease in the reserpinetreated rats but showed no change after correction for body weight. Except for one experimental group where the trypsinogen concentration was higher in the 14-day-old reserpine pups, no changes in enzyme concentrations were detected between the control and treated pups ( Table 2 ). The mean content of pancreatic enzymes showed a modest decrease in most cases. Again, when corrected for body weights, no consistent decrease in enzyme content in the pancreas was discerned. Administration of hydrocortisone to both control and treated pups at the 12th day of age caused significant increases in the pancreatic mass and in total protein and DNA content per pancreas in both reserpine and control pups at the age of 14 days (Table 3) . Further, the magnitude of the increase in the treated pups was similar to that found in the control pups.
Both amylase and lipase concentrations were increased in the hydrocortisone-treated pups whether they were from the control or reserpine-treated groups. Trypsinogen concentration, however, showed minimal if any changes at all (Table 4) . Total contents of these three enzymes were, however, increased reflecting an increase in the pancreatic mass and enzyme concentrations.
In order to evaluate the secretion of pancreatic enzymes by the control and reserpine-treated pups, total contents of pancreatic enzymes in the intestinal lumen were also measured. The crease the intestinal contents of trypsin, amylase,\and lipase. To see if these were reflections of a decreased secretion by the pancreas, pancreatic acini were prepared from 14-day-old pups from both control and reserpine-treated groups and examined for their responsiveness to varying concentrations of carbachol and octapeptide of cholecystokinin. Figure 1 compares the secretory responses in terms of amylase release of the pancreas of the control pups and the reserpine-treated pups. With the pancreatic acini from control pups, typical dose-response profiles were seen with both secretagogues. With the pancreatic acini from reserpinized pups, a dose response was also seen but there were significant reductions in the percentage of amylase released at all concentrations of carbachol and at the three high concentrations (100, 300, and 1000 pM) of octapeptide of CCK used.
DISCUSSION
Chronic administration of reserpine to adult rats has been shown to inhibit the secretion of fluid and bicarbonate from their exocrine pancreases (1 2, 13), and reduce the secretion of pancreatic enzymes in response to secretagogue stimulation (10) . These conditions induced by chronic reserpine treatment are similar to those found in the pancreas of cystic fibrosis patients with accompanying pancreatic insufficiency. In humans, pancreatic dysfunction in cystic fibrosis more commonly develops in the early postnatal period (18, 19) . Any disturbance should presumably occur during or before this stage. As such, it may be more appropriate to focus the effect during the suckling period in order to obtain further insight into its pathogenesis. ".z '*
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both reserpine-treated and control pups, it showed an equal if g g not higher value in the case of the reserpine-treated pups. Simic, * larly, the liver weights when normalized against the body weight also showed no difference between the two groups of pups. The amylase and lipase. In the present study, these hypertrophic effects were observed in both the control and reserpinized pups following hydrocortisone treatments. Thus, the pancreas of the reserpinized pups retained the basic capability of biosynthesis of pancreatic protein, DNA, and particularly the exocrine enzymes both during the normal chronological and in precocious development as induced by hydrocortisone. The pancreases of the reserpine-treated rat pups were, however, not fully functional. The first hint was provided by the general decrease in pancreatic enzymes recovered from the small intestinal contents of these pups as compared to those obtained from control pups. This suggested a reduced secretory capacity by the pancreases of the reserpine-treated rat pups. Results from in vitro studies using dispersed acini prepared from the pancreases of the reserpine-treated and control pups demonstrated a decreased responsiveness in terms of amylase release of the acini from reserpine-treated pancreases as compared to those from control pancreases when subjected to stimulation by carbachol or octapeptide of ch~lec~stbkinin. In this particular aspect, the pancreases of the reserpine-treated pups are identical to those found in adult rats (1 3, 17) .
Our results showed that chronic reserpine treatment of rat pups, at the dosage used, did not disturb their exocrine pancreatic development in terms of pancreatic mass corrected for body weights or of their concentrations and contents of pancreatic exocrine enzymes. As such, rat pups differ from adult reserpine-treated rats in that the latter showed a selective increase in their pancreatic proteases. The difference perhaps can be attributed to the much lower dose of reserpine used in our study (50 versus 500 pg/kg body weight) and/or more importantly, to the develo~mental stages of the animals. Resemine treatment. however, significantly-impaired the secretory capacity of the pancreatic acini in both the pup and the adult. Considering the results together, reserpine may have a specific and potent action that interferes with the stimulus-secretion coupling mechanism of the pancreatic acini. On the other hand, reserpine treatment led to significantly decreased body weight, suggesting, perhaps, a partial malnutrition which may also be the cause of reduced responsiveness of the pancreas to secretagogues.
